UNSPSC 51202413: Secukinumab

This classification denotes an immunosuppressant that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DLG4EML025, generally known as secukinumab. European Medicines Agency schedules secukinumab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB33242. The term SECUKINUMAB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 1, 2010 List 63). Most nations, for tariff and trade purposes, schedule SECUKINUMAB under HS 29349990 and SITC 51579. SMILES: none.

UNSPSC 51202413 Secukinumab, a Commodity code, shows material misalignment between its nominal scope (a biologic immunosuppressant for psoriasis and inflammatory conditions) and recent state and local procurement activity tagged under it. The recent opportunities on record—naloxone and drug deactivation systems, medical and first aid supplies for fire rescue operations, and generic multi-source pharmaceuticals and OTC products through cooperative purchasing—do not center on secukinumab or specialty biologics procurement. The code appears to serve as a catch-all pharmaceutical tag in some state and local systems, capturing diverse health-supply purchases rather than the specific therapeutic class the code name denotes.

Activity includes diverse issuing bodies: a county health department (Seminole County, Florida), a state health agency (Texas Health and Human Services Commission), a municipal fire department (City of Tampa), and a multi-state cooperative purchasing alliance (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota, Oregon, and other participants). Geographic spread reflects activity in Florida, Texas, and the upper Midwest. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026; due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the City of Tampa's ITB 26-P-00145 (posted March 25, 2026; due March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, estimated at $700,000, with a sheltered market set-aside for certified Small Local Business Enterprises and a 5 percent SLBE bid discount; and MMCAP's RFP S1070000015802 (posted January 20, 2026; due March 26, 2026) for generic pharmaceuticals and OTC products through authorized wholesalers with May 15, 2026 market-availability requirement and July 1, 2026 contract effective date. Vendors pursuing work under this code should verify the actual therapeutic or product scope in each RFP or IFB, as the code's pharmaceutical-classification breadth does not reliably predict the specific goods or services state and local procurement offices intend.